Evidence mapPaperPMID 36844403Full record

ReviewFrontiers in cellular and infection microbiology2023

Diagnosis of cerebral malaria: Tools to reduce

Pranavi Muppidi, Emily Wright, Samuel C Wassmer, Himanshu Gupta

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Exploring the genetic progression of MDR1 inCurrent research in microbial sciences · 2024
    Article
  13. The RNA mFrontiers in cellular and infection microbiology · 2024
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pranavi MuppidiDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Emily WrightDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Samuel C WassmerDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Himanshu GuptaDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
London School of Hygiene & Tropical Medicine · GBGLA University · IN

Funding

Medical Research Council MR/S009450/1NIAID NIH HHS R21 AI142472NIAID NIH HHS U19 AI089676
6 · The paper itself

Abstract

Cerebral malaria (CM) is a major cause of mortality in Plasmodium falciparum (Pf) infection and is associated with the sequestration of parasitised erythrocytes in the microvasculature of the host's vital organs. Prompt diagnosis and treatment are key to a positive outcome in CM. However, current diagnostic tools remain inadequate to assess the degree of brain dysfunction associated with CM before the window for effective treatment closes. Several host and parasite factor-based biomarkers have been suggested as rapid diagnostic tools with potential for early CM diagnosis, however, no specific biomarker signature has been validated. Here, we provide an updated review on promising CM biomarker candidates and evaluate their applicability as point-of-care tools in malaria-endemic areas.

Indexed as

Brain DiseasesMalaria, CerebralMalaria, FalciparumHumansMicrovesselsPlasmodium falciparumbiomarkerscerebral malariadiagnosisplasmodium falciparumtherapeutic avenues

Identifiers

PMID36844403
PMCPMC9947298
OpenAlexW4319767203

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.